Upload
Featured Recent Articles Topics Login Upload

Search Results for 'dose study'

dose study published presentations and documents on DocSlides.

Abstract #323 : An open-label, dose escalation, Phase I/II study to assess safety, tolerability, im
Abstract #323 : An open-label, dose escalation, Phase I/II study to assess safety, tolerability, im
by caitlin
J. Bennouna. 1. , A. Sibille. 2. , C. Debruyne. 3....
This study compares two statistical modeling approaches to construct summary dose-response curves f
This study compares two statistical modeling approaches to construct summary dose-response curves f
by sylvia
Abstract. Comparing two statistical models for low...
MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study
MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study
by chiquity
to . Determine the Maximum Tolerated Dose for the ...
THE PARADOX OF HUMAN EQUIVALENT DOSE FORMULA – A CANONICAL CASE STUDY OF PIROXICAM (FELDENE) IN MONOGASTRIC ANIMALS
THE PARADOX OF HUMAN EQUIVALENT DOSE FORMULA – A CANONICAL CASE STUDY OF PIROXICAM (FELDENE) IN MONOGASTRIC ANIMALS
by min-jolicoeur
THE PARADOX OF HUMAN EQUIVALENT DOSE FORMULA – ...
Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
by danika-pritchard
Original Article Low-Dose Aspirin for Preventin...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Thyroid dose estimation for epidemiologic studies
Thyroid dose estimation for epidemiologic studies
by pamella-moone
André Bouville. . (NCI, retired) and . Vladimir...
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
by alexa-scheidler
Phase I Study of Olaparib and Temozolomide, in pa...
IMPAACT 2010 Pharmacy, Study Drug, and Concomitant Medication Considerations at Entry
IMPAACT 2010 Pharmacy, Study Drug, and Concomitant Medication Considerations at Entry
by pamella-moone
Protocol References. Section. Title. 6.2. Entry V...
Posters: 1 Minute Previews
Posters: 1 Minute Previews
by elina
C. areers . and. A. cademic. L. iaison . C. ommitt...
SANGUINATE TM Toxicology and Safety Determination
SANGUINATE TM Toxicology and Safety Determination
by isabella
October 20, 2014. Hemant . Misra. , PhD. hmisra@pr...
Department of Pharmacology
Department of Pharmacology
by jasmine
1. INTRODUCTION TO THE STUDY OF PHARMACOLOGY. . N...
The Appropriate Use of Activated Charcoal in
The Appropriate Use of Activated Charcoal in
by sylvia
4407 Pharmaceutical and Toxicological Approaches A...
Radiology Section
Radiology Section
by anya
12 12 Correlation of Anteroposterior Diameter of ...
DEVELOPMENT OF RV3 ROTAVIRUS VACCINE
DEVELOPMENT OF RV3 ROTAVIRUS VACCINE
by williams
Mahendra. . Suhardono. Production Director. 11. t...
According to template WWCLINER102SD02 VERSION N02 05OCT2007Thes
According to template WWCLINER102SD02 VERSION N02 05OCT2007Thes
by ceila
Study centers The study was conducted in 25 cente...
Clinical Trials Approach
Clinical Trials Approach
by natalia-silvester
and the Pediatric Trials Network. Danny Benjamin,...
The Soluble Guanylate Cyclase Stimulator Vericiguat in Wors
The Soluble Guanylate Cyclase Stimulator Vericiguat in Wors
by alexa-scheidler
SOCRATES-REDUCED . D. ose Finding . P. hase II ....
Low-dose Tricyclic Antidepressants (TCA) for IBS
Low-dose Tricyclic Antidepressants (TCA) for IBS
by colton732
Original Article. EBGI Summary. Article covered: ....
Crysvita ® ( burosumab-twza
Crysvita ® ( burosumab-twza
by eleanor
):. A . Summary of Clinical Trial Data. MRCP-KRN23...
1 Endothelium: Vasculoprotective
1 Endothelium: Vasculoprotective
by wilson
, Stabilizes BBB integrity. Neurons:. Direct Neur...
Single dose liposomal amphotericin for asymptomatic CRAG+ persons
Single dose liposomal amphotericin for asymptomatic CRAG+ persons
by eleanor
Radha Rajasingham. December 10, 2017. Background. ...
Vaccines in the Pipeline:
Vaccines in the Pipeline:
by emma
What’s New or Coming Soon. Sharon Rush, . R.Ph. ...
European Medicines Agency 7 Westferry Circus Canary Wharf London E1
European Medicines Agency 7 Westferry Circus Canary Wharf London E1
by oconnor
ICH Topic E 12 Evaluation of New An ICH PRINCIPL...
Safety Assessment ofDi2ethylhexylphthalate DEHPReleased from PVC
Safety Assessment ofDi2ethylhexylphthalate DEHPReleased from PVC
by walsh
TABLE OF CONTENTSPage 2.1Parenteral Expo...
Update on Marijuana for the Treatment of Epilepsy
Update on Marijuana for the Treatment of Epilepsy
by CuteKitten
Brenda Porter MD, PhD. Cannabis: A complex mixtur...
Lung Trials for discussion
Lung Trials for discussion
by BookWorm
at CSSG meeting. May 2019. CanopyA. - ACZ885/Cana...
MErCuRIC1: A phase 1 Multi-Centre Study of
MErCuRIC1: A phase 1 Multi-Centre Study of
by badra
Crizotinib. (. cMET. inhibitor) Combined . with ...
Survey of available testing methods for low dose toxicity, including new
Survey of available testing methods for low dose toxicity, including new
by finley
in-vivo . and . in vitro. methods. John R. Bucher...
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
by leah
Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...
This is a preprint and has not yet been peer reviewed
This is a preprint and has not yet been peer reviewed
by unita
1Effectiveness of first dose of COVID-19 vaccines ...
589593 2020 3Sahin U et al COVID
589593 2020 3Sahin U et al COVID
by fiona
19 vaccine 2 Day 3-4 After the initial first vacci...
x0000x0000 xMCIxD 0 xMCIxD 0 HIGHLIGHTS OF PRESCRIBING INFORMATION
x0000x0000 xMCIxD 0 xMCIxD 0 HIGHLIGHTS OF PRESCRIBING INFORMATION
by sophie
Regularly monitor the tube to ensure proper functi...
Kirk W Johnson PhD Ann C Neale Allan Gordon MD PhD Diva Del Carmen De
Kirk W Johnson PhD Ann C Neale Allan Gordon MD PhD Diva Del Carmen De
by cora
MON 056Orthosteric SiteAllosteric SiteInsulinRecep...
Presented at the American Society of Clinical Oncology ASCO Annual Mee
Presented at the American Society of Clinical Oncology ASCO Annual Mee
by eliza
8 2021Patientswithhigh-doselymphodepletionCohort2w...
During the preparation of health criteria documents and at experts mee
During the preparation of health criteria documents and at experts mee
by alis
Acronyms and abbreviations used in the text CAS Ch...
TOXICITY REVIEW
TOXICITY REVIEW
by yvonne
FOR BIS(2 - ETHYLHEXYL)ADIPATE (DEHA) Contract N...
During the preparation of health criteria documents and at experts mee
During the preparation of health criteria documents and at experts mee
by audrey
Acronyms and abbreviations used in the text CAS Ch...
434 Has Potential to Treat Complicated Urinary Tract Infections ( ...
434 Has Potential to Treat Complicated Urinary Tract Infections ( ...
by daisy
Abstract Methods Printed by TP - cUTI ) J . SUTCL...
JAMA Pediatrics Journal Club Slides:
JAMA Pediatrics Journal Club Slides:
by briana-ranney
JAMA Pediatrics Journal Club Slides: Insulin in ...